• Follow the Money: Most Extensive Liver Cirrhosis Study Funded, Expanded Biomedical Research Program, Antibody Development, More

    Clinical Research News | Newcastle University, University of Edinburgh, and Boehringer Ingelheim have received funding to begin the most extensive clinical study into liver cirrhosis ever; the University of New England has received an award from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence to be named the UNE Center for Cell Signaling Research; Oxitope Pharma and Arxx Therapeutics have merged to form Calluna Pharma Inc. (Calluna) and intend to work on a pipeline of selective antibodies that target inflammatory and fibrotic indications; more.

    Jan 30, 2024

  • Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

    Clinical Research News | Researchers at the CNIO (Spanish National Cancer Research Centre) are forwarding the idea that metastasis, rather than the primary tumor, should be the focus of cancer treatment, which would both further the cause of personalized medicine and generate biomarkers of sensitivity or resistance to specific drugs.

    Jan 24, 2024